Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits
So when a business like Vertex Pharmaceuticals (NASDAQ: VRTX) releases some new data on a potential blockbuster that could be ...
stocknews19h
3 Pharma Stocks to Watch as Gene Therapy Gains Momentum
The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...
bovnews3h
Vertex Pharmaceuticals Incorporated (VRTX) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
On Wednesday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $470.05 which represents a decrease of $-4.86 or -1.02% from the prior close of $474.91. The stock ...
Zacks.com on MSN2d
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
Vertex Pharmaceuticals: A Long-Term Growth Monster
Vertex Pharmaceuticals dominates the cystic fibrosis market with a promising pipeline and strategic M&A activity. Read why I ...
Vertex Pharmaceuticals’ Promising Developments and Strategic Market Positioning Reinforce Buy Rating
Vertex Pharmaceuticals (VRTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
BioSpace3d
Vertex Unveils Full Phase III Data for Non-Opioid Pain Candidate, Touts Safety Profile
BMO Capital Markets analyst Evan Seigerman in a note to investors said the late-stage data for Vertex’s experimental ...
Vertex Pharmaceuticals: The Future Looks Bright, But It May Be A Choppy Ride
Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.
Vertex Pharmaceuticals’ Suzetrigine: A Promising Non-Opioid Solution to Acute Pain Management
Vertex Pharmaceuticals (VRTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
Impacts2d
The Role of Vertex Pharmaceuticals in Boston’s Biotech Boom
Boston has become world-famous for its booming biotech industry. Over the past 20 years, the city has been buzzing with ...
BioSpace5h
Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs
Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in ...
The Pharma Letter3d
Vertex says Phase III data highlight suzetrigine’s potential
Vertex Pharmaceuticals on Sunday presented its pivotal Phase III data on suzetrigine, an investigational, oral, highly ...